Logo image of CMCOM.AS

CM.COM (CMCOM.AS) Stock Fundamental Analysis

AMS:CMCOM - Euronext Amsterdam - NL0012747059 - Common Stock - Currency: EUR

6.47  +0.42 (+6.94%)

Fundamental Rating

2

Taking everything into account, CMCOM scores 2 out of 10 in our fundamental rating. CMCOM was compared to 101 industry peers in the Software industry. CMCOM may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CMCOM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CMCOM had negative earnings in the past year.
In the past year CMCOM had a positive cash flow from operations.
In the past 5 years CMCOM always reported negative net income.
In multiple years CMCOM reported negative operating cash flow during the last 5 years.
CMCOM.AS Yearly Net Income VS EBIT VS OCF VS FCFCMCOM.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

With a Return On Assets value of -11.79%, CMCOM is not doing good in the industry: 71.72% of the companies in the same industry are doing better.
The Return On Equity of CMCOM (-395.79%) is worse than 83.84% of its industry peers.
Industry RankSector Rank
ROA -11.79%
ROE -395.79%
ROIC N/A
ROA(3y)-12.09%
ROA(5y)-10.1%
ROE(3y)-160.78%
ROE(5y)-102.61%
ROIC(3y)N/A
ROIC(5y)N/A
CMCOM.AS Yearly ROA, ROE, ROICCMCOM.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

The Gross Margin of CMCOM (30.20%) is worse than 76.77% of its industry peers.
CMCOM's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CMCOM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.67%
GM growth 5YN/A
CMCOM.AS Yearly Profit, Operating, Gross MarginsCMCOM.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1

2. Health

2.1 Basic Checks

CMCOM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CMCOM has about the same amount of shares outstanding.
Compared to 5 years ago, CMCOM has more shares outstanding
CMCOM has a worse debt/assets ratio than last year.
CMCOM.AS Yearly Shares OutstandingCMCOM.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CMCOM.AS Yearly Total Debt VS Total AssetsCMCOM.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 1.25, we must say that CMCOM is in the distress zone and has some risk of bankruptcy.
CMCOM has a worse Altman-Z score (1.25) than 64.65% of its industry peers.
CMCOM has a debt to FCF ratio of 87.09. This is a negative value and a sign of low solvency as CMCOM would need 87.09 years to pay back of all of its debts.
CMCOM's Debt to FCF ratio of 87.09 is in line compared to the rest of the industry. CMCOM outperforms 42.42% of its industry peers.
CMCOM has a Debt/Equity ratio of 16.20. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CMCOM (16.20) is worse than 83.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 16.2
Debt/FCF 87.09
Altman-Z 1.25
ROIC/WACCN/A
WACC6.54%
CMCOM.AS Yearly LT Debt VS Equity VS FCFCMCOM.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CMCOM has a Current Ratio of 0.93. This is a bad value and indicates that CMCOM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.93, CMCOM is doing worse than 71.72% of the companies in the same industry.
CMCOM has a Quick Ratio of 0.93. This is a bad value and indicates that CMCOM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.93, CMCOM is doing worse than 68.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.93
CMCOM.AS Yearly Current Assets VS Current LiabilitesCMCOM.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.98% over the past year.
Looking at the last year, CMCOM shows a very strong growth in Revenue. The Revenue has grown by 53.47%.
Measured over the past years, CMCOM shows a small growth in Revenue. The Revenue has been growing by 4.98% on average per year.
EPS 1Y (TTM)5.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-84.53%
Revenue 1Y (TTM)53.47%
Revenue growth 3Y4.98%
Revenue growth 5YN/A
Sales Q2Q%112.74%

3.2 Future

Based on estimates for the next years, CMCOM will show a very strong growth in Earnings Per Share. The EPS will grow by 62.63% on average per year.
Based on estimates for the next years, CMCOM will show a quite strong growth in Revenue. The Revenue will grow by 10.52% on average per year.
EPS Next Y118.42%
EPS Next 2Y62.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.81%
Revenue Next 2Y8.93%
Revenue Next 3Y10.52%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMCOM.AS Yearly Revenue VS EstimatesCMCOM.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CMCOM.AS Yearly EPS VS EstimatesCMCOM.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8 -1

2

4. Valuation

4.1 Price/Earnings Ratio

CMCOM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 134.60, the valuation of CMCOM can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CMCOM indicates a slightly more expensive valuation: CMCOM is more expensive than 62.63% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CMCOM is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 134.6
CMCOM.AS Price Earnings VS Forward Price EarningsCMCOM.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

CMCOM's Enterprise Value to EBITDA is on the same level as the industry average.
CMCOM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 158.88
EV/EBITDA 23.55
CMCOM.AS Per share dataCMCOM.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CMCOM's earnings are expected to grow with 62.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.63%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CMCOM!.
Industry RankSector Rank
Dividend Yield N/A

CM.COM

AMS:CMCOM (3/7/2025, 7:00:00 PM)

6.47

+0.42 (+6.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)04-17 2025-04-17
Inst Owners4.83%
Inst Owner ChangeN/A
Ins Owners45.5%
Ins Owner ChangeN/A
Market Cap207.82M
Analysts78.18
Price Target8.66 (33.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.32%
Revenue NY rev (3m)-2.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 134.6
P/S 0.51
P/FCF 158.88
P/OCF 11.33
P/B 30.37
P/tB N/A
EV/EBITDA 23.55
EPS(TTM)-0.93
EYN/A
EPS(NY)0.05
Fwd EY0.74%
FCF(TTM)0.04
FCFY0.63%
OCF(TTM)0.57
OCFY8.83%
SpS12.72
BVpS0.21
TBVpS-2.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.79%
ROE -395.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.2%
FCFM 0.32%
ROA(3y)-12.09%
ROA(5y)-10.1%
ROE(3y)-160.78%
ROE(5y)-102.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.67%
GM growth 5YN/A
F-Score5
Asset Turnover1.78
Health
Industry RankSector Rank
Debt/Equity 16.2
Debt/FCF 87.09
Debt/EBITDA 9.22
Cap/Depr 53.7%
Cap/Sales 4.17%
Interest Coverage N/A
Cash Conversion 152.51%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.93
Altman-Z 1.25
F-Score5
WACC6.54%
ROIC/WACCN/A
Cap/Depr(3y)82.13%
Cap/Depr(5y)88.9%
Cap/Sales(3y)6.71%
Cap/Sales(5y)6.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-84.53%
EPS Next Y118.42%
EPS Next 2Y62.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)53.47%
Revenue growth 3Y4.98%
Revenue growth 5YN/A
Sales Q2Q%112.74%
Revenue Next Year7.81%
Revenue Next 2Y8.93%
Revenue Next 3Y10.52%
Revenue Next 5YN/A
EBIT growth 1Y11.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7675.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y105.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y612.23%
OCF growth 3Y84.76%
OCF growth 5YN/A